Literature DB >> 7157667

The cardiomyopathy of Wilson's disease. Myocardial alterations in nine cases.

S M Factor, S Cho, I Sternlieb, I H Scheinberg, S Goldfischer.   

Abstract

Though myocardial alterations are well recognized in haemochromatosis, little attention has been paid to the cardiac changes in Wilson's disease. To define the extent of myocardial degeneration in newly diagnosed or chronically treated Wilson's disease, we reviewed the autopsy findings in 9 cases with this condition. We compared our observations with those in 3 control cases, selected for comparable age and with liver disease having no known association with cardiac degeneration. Our results revealed cardiac hypertrophy in 5 out of 9 cases of Wilson's disease. There was evidence of interstitial and replacement fibrosis, intramyocardial small vessel sclerosis and focal inflammatory cell inflammation to a variable degree in all cases. One case had AV nodal degeneration, and a 15 year old boy had severe atherosclerosis of the left main coronary artery. Two patients died suddenly, presumably secondary to an arrhythmia; one of these patients had the most marked myocardial alterations. We could not correlate these changes specifically with the tissue levels of copper, treatment with D-penicillamine, or the presence of cirrhosis. We conclude that there are definite morphological abnormalities in the hearts of patients with Wilson's disease consistent with a cardiomyopathy. Though the myocardial changes were non-specific, the fact that 2 patients died suddenly, suggests the need for a prospective study of cardiac function in these patients in the future.

Entities:  

Mesh:

Year:  1982        PMID: 7157667     DOI: 10.1007/bf00496571

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  24 in total

1.  Histochemical, ultrastructural and structural changes in primary cardiomyopathy and in cobalt cardiomyopathy.

Authors:  E G Olsen
Journal:  Postgrad Med J       Date:  1972-12       Impact factor: 2.401

2.  [Diagnosis of the abdominal form of Wilson's disease].

Authors:  G Brandt
Journal:  Dtsch Med Wochenschr       Date:  1972-12-29       Impact factor: 0.628

3.  Neutron activation analysis ofr copper in biological material applied to Wilson's disease.

Authors:  G S Fell; H Smith; R A Howie
Journal:  J Clin Pathol       Date:  1968-01       Impact factor: 3.411

4.  Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.

Authors:  R R Lindquist
Journal:  Arch Pathol       Date:  1969-04

5.  Lead cardiomyopathy in mice: a correlative ultrastructural and blood level study.

Authors:  M Y Khan; M Buse; D B Louria
Journal:  Arch Pathol Lab Med       Date:  1977-02       Impact factor: 5.534

6.  Clinical and morphological features of human hypertensive-diabetic cardiomyopathy.

Authors:  S M Factor; T Minase; E H Sonnenblick
Journal:  Am Heart J       Date:  1980-04       Impact factor: 4.749

7.  Cardiac conduction system in hemochromatosis: clinical and pathologic features of six patients.

Authors:  V J Vigorita; G M Hutchins
Journal:  Am J Cardiol       Date:  1979-09       Impact factor: 2.778

8.  Heart involvement in hepatolenticular degeneration.

Authors:  E M Azevedo; M Scaff; E R Barbosa; A E Neto; H M Canelas
Journal:  Acta Neurol Scand       Date:  1978-11       Impact factor: 3.209

9.  Secondary athrocytotic cardiomyopathy--heart damage due to Wilson's disease.

Authors:  B Kaduk; K Metze; P F Schmidt; G Brandt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

10.  Cytochemical methods for copper. Semiquantitative screening procedure for identification of abnormal copper levels in liver.

Authors:  R D Irons; E A Schenk; J C Lee
Journal:  Arch Pathol Lab Med       Date:  1977-06       Impact factor: 5.534

View more
  11 in total

1.  P wave dispersion is prolonged in patients with Wilson's disease.

Authors:  Nurcan Arat; Sabite Kacar; Zehra Golbasi; Meral Akdogan; Yeliz Sokmen; Sedef Kuran; Ramazan Idilman
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 2.  Insights into the management of Wilson's disease.

Authors:  Mohmadshakil Kathawala; Gideon M Hirschfield
Journal:  Therap Adv Gastroenterol       Date:  2017-10-03       Impact factor: 4.409

3.  Elevated serum brain natriuretic peptide and matrix metalloproteinases 2 and 9 in Wilson's disease.

Authors:  Nan Cheng; Honghao Wang; Jianjian Dong; Suyue Pan; Xun Wang; Yongsheng Han; Yongzhu Han; Renmin Yang
Journal:  Metab Brain Dis       Date:  2015-06-17       Impact factor: 3.584

4.  Cardiac involvement in Wilson disease.

Authors:  Z Hlubocká; Z Marecek; A Linhart; E Kejková; L Pospísilová; P Martásek; M Aschermann
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

5.  Autonomic Dysfunction in Wilson's Disease: A Comprehensive Evaluation during a 3-Year Follow Up.

Authors:  Kai Li; Charlotte Lindauer; Rocco Haase; Heinz Rüdiger; Heinz Reichmann; Ulrike Reuner; Tjalf Ziemssen
Journal:  Front Physiol       Date:  2017-10-10       Impact factor: 4.566

6.  Cardiac and autonomic function in patients with Wilson's disease.

Authors:  Silvio Quick; Ulrike Reuner; Marie Weidauer; Charlotte Hempel; Felix Martin Heidrich; Christoph Mues; Krunoslav Michael Sveric; Karim Ibrahim; Heinz Reichmann; Axel Linke; Uwe Speiser
Journal:  Orphanet J Rare Dis       Date:  2019-01-28       Impact factor: 4.123

7.  Cardiac arrest in Wilson's disease after curative liver transplantation: a life-threatening complication of myocardial copper excess?

Authors:  Emanuele Bobbio; Niklas Forsgard; Anders Oldfors; Piotr Szamlewski; Entela Bollano; Bert Andersson; Marie Lingbrant; Niklas Bergh; Kristjan Karason; Christian L Polte
Journal:  ESC Heart Fail       Date:  2019-01-08

8.  Cardiac assessment in Wilson's disease patients based on electrocardiography and echocardiography examination.

Authors:  Małgorzata Buksińska-Lisik; Tomasz Litwin; Tomasz Pasierski; Anna Członkowska
Journal:  Arch Med Sci       Date:  2017-09-07       Impact factor: 3.318

9.  Evaluation of Myocardial Strain Using Cardiac Magnetic Resonance in Patients with Wilson's Disease.

Authors:  Kun Zhang; Ulrike Reuner; Charlotte Hempel; Uwe Speiser; Karim Ibrahim; Frank R Heinzel; Burkert Pieske; Marian Christoph; Felix M Heidrich; Silvio Quick
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

10.  The impact of Wilson disease on myocardial tissue and function: a cardiovascular magnetic resonance study.

Authors:  Janek Salatzki; Isabelle Mohr; Jannick Heins; Mert H Cerci; Andreas Ochs; Oliver Paul; Johannes Riffel; Florian André; Kristóf Hirschberg; Matthias Müller-Hennessen; Evangelos Giannitsis; Matthias G Friedrich; Uta Merle; Karl Heinz Weiss; Hugo A Katus; Marco Ochs
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-24       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.